• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Clinical Research Advantage adds clinical trials in rural Nebraska

Clinical Research Advantage adds clinical trials in rural Nebraska

March 2, 2012
CenterWatch Staff

Tempe, Ariz.-based Clinical Research Advantage (CRA), a provider of research services to pharmaceutical companies and CROs, will begin offering patients throughout rural Nebraska the opportunity to participate in additional clinical trials.

Currently, CRA offers trials through its site at Prairie Fields Family Medicine (PPFM), a large clinic in Fremont, Neb., with three physicians and three physician assistants.

The additional trials are the result of CRA adding another physician practice to its research site presence at PPFM, with three physicians, three physician assistants and a nurse practitioner.

Under the direction of Dr. Thomas McKnight, president of PFFM and principal investigator for clinical trials, Prairie Fields Family Medicine and 23rd Family Medicine, a separate family practice group based at the same location, are making study opportunities available to patients for diagnosis and vaccines that span, among others, pediatric vaccines (some may satisfy school requirements); Chronic Obstructive Pulmonary Disease (COPD); hypertension and type 2 diabetes.

“Our expanded relationship with 23rd Family Medicine stands to bring many benefits to the communities spread throughout rural Nebraska,” said Tony Romero, CRA’s director of operations, who oversees the Nebraska market operations. “With this arrangement, we have opportunities to bring patients access to cutting-edge medications and education regarding their conditions that could potentially enhance their quality of life by changing their state of health.”

“CRA has worked closely with my practice and physicians for the past year, and has continually demonstrated to patients the advantages they can reap from participation in sponsored trials,” said McKnight. “It’s dedicated companies like CRA that are making a difference in the level of healthcare made available across local medical communities throughout the country, particularly here in rural Nebraska.”

CRA forges partnerships with medical practices whose physicians serve as principal investigators of the clinical trials it manages and oversees. As a trial management organization (TMO), CRA operates from 33 sites across 17 geographic markets nationwide, helping sponsors bring drugs to market more quickly and efficiently. In Nebraska and Western Iowa, CRA operates four other sites.

 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing